U-Neuron Biomedical PEG Ratio

U-Neuron Biomedical's peg ratio stands at -167.04. That is below the Healthcare sector average of 27.75. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

U-Neuron Biomedical sits lower the Healthcare benchmark (27.75) with a PEG ratio of -167.04. That is roughly 701.9% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether -167.04 is attractive depends on U-Neuron Biomedical's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how U-Neuron Biomedical's PEG ratio evolved across reporting periods, while the comparison chart places 6973.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. U-Neuron Biomedical's reading of -167.04 (sector avg 27.75) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.